LENZ Therapeutics (LENZ) EPS (Basic) (2020 - 2026)
LENZ Therapeutics (LENZ) reported EPS (Basic) of -$1.32 for Q1 2026, down 149.06% year-over-year from $2.69 in Q1 2025, and down 10.0% on a QoQ basis from -$1.2 in Q4 2025.
LENZ Therapeutics (LENZ) has 7 years of EPS (Basic) data on file, last reported at -$1.32 in Q1 2026.
- Quarterly EPS (Basic) fell 149.06% year-over-year to -$1.32 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.64 (down 111.63% YoY) and the FY2025 annual result came in at -$2.85, down 21.79% from the prior year.
- EPS (Basic) slipped to -$1.32 in Q1 2026 per LENZ's latest filing, from -$1.2 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.38 in Q3 2024 and bottomed at -$12.05 in Q4 2023.
- The 5-year median for EPS (Basic) is -$0.53 (2025), against an average of -$2.73.
- The widest annual swing landed in 2023, when EPS (Basic) tumbled 2638.64%; it then jumped 96.6% in 2024.
- Tracing LENZ's EPS (Basic) over 5 years: stood at -$0.44 in 2022, then sank by 2638.64% to -$12.05 in 2023, then jumped by 96.6% to -$0.41 in 2024, then slumped by 192.68% to -$1.2 in 2025, then decreased by 10.0% to -$1.32 in 2026.
- Per Business Quant, the three latest LENZ EPS (Basic) figures stand at -$1.32 (Q1 2026), -$1.2 (Q4 2025), and -$0.59 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.55 |
| 10 | LENZ Therapeutics | 235.77 Mn | 235.77 Mn | 825,000.00 | -1.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.32 |
| Dec 31, 2025 | -1.20 |
| Sep 30, 2025 | -0.59 |
| Jun 30, 2025 | -0.53 |
| Mar 31, 2025 | -0.53 |
| Dec 31, 2024 | -0.41 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | -0.40 |
| Mar 31, 2024 | -3.53 |
| Dec 31, 2023 | -12.05 |
| Sep 30, 2023 | -9.62 |
| Jun 30, 2023 | -7.53 |
| Mar 31, 2023 | -6.50 |
| Dec 31, 2022 | -0.44 |
| Sep 30, 2022 | -0.45 |
| Jun 30, 2022 | -0.48 |
| Mar 31, 2022 | -0.48 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | -0.28 |
| Jun 30, 2021 | -3.45 |
| Mar 31, 2021 | -5.75 |
| Dec 31, 2020 | -27.40 |
| Sep 30, 2020 | -1.00 |
| Jun 30, 2020 | -0.56 |